|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 495/04 | (2006.01) |
| A61P 35/00 | (2006.01) | ||
| A61P 35/02 | (2006.01) | ||
| A61P 43/00 | (2006.01) |
| (11) | Number of the document | 3436463 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17719053.5 |
| Date of filing the European patent application | 2017-03-27 | |
| (97) | Date of publication of the European application | 2019-02-06 |
| (45) | Date of publication and mention of the grant of the patent | 2021-06-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/024226 |
| Date | 2017-03-27 |
| (87) | Number | WO 2017/172565 |
| Date | 2017-10-05 |
| (30) | Number | Date | Country code |
| 201662314080 P | 2016-03-28 | US | |
| 201662367842 P | 2016-07-28 | US |
| (72) |
IWATA, Kentaro , JP
MIZUNO, Masahiro , JP
MAEDA, Kazuhiro , JP
YASUMA, Tsuneo , JP
HOMMA, Misaki , JP
OGURO, Yuya , JP
TAYA, Naohiro , JP
ZHU, Lei , US
BAILEY, John, Daniel , US
LANGSTON, Marianne , US
PATIL, Siddhesh, Dinanath , US
GOUR, Shruti , US
ROY, Lilly , US
|
| (73) |
Takeda Pharmaceutical Company Limited ,
1-1 Doshomachi 4-chome
Chuo-ku, Osaka-shi, Osaka 541-0045,
JP
|
| (54) | CRYSTALLINE FORMS OF 2-[(2S)-1-AZABICYCLO[2.2.2]OCT-2-YL]-6-(3-METHYL-1H- PYRAZOL-4-YL)THIENO[3,2-D]PYRIMIDIN-4(3H)-ONE HEMIHYDRATE |
| CRYSTALLINE FORMS OF 2-[(2S)-1-AZABICYCLO[2.2.2]OCT-2-YL]-6-(3-METHYL-1H- PYRAZOL-4-YL)THIENO[3,2-D]PYRIMIDIN-4(3H)-ONE HEMIHYDRATE |